SAN JOSE, Calif., Aug. 7, 2023 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) ANIX, a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic, has begun enrolling subjects in a treatment arm evaluating the combination of the Company’s breast cancer…Read More
Anixa Biosciences Announces Opening of Enrollment for Keytruda Arm in Ongoing Breast Cancer Vaccine Clinical Trial Anixa Biosciences NASDAQANIX Merck Co NYSEMRK
